🇺🇸 FDA
Patent

US 9856467

Modified factor X polypeptides and uses thereof

granted A61KA61K38/36A61K38/482

Quick answer

US patent 9856467 (Modified factor X polypeptides and uses thereof) held by Catalyst Biosciences, Inc. expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Catalyst Biosciences, Inc.
Grant date
Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
35
CPC classes
A61K, A61K38/36, A61K38/482, A61K38/4846, A61P